Trevogrumab

From WikiMD's WELLNESSPEDIA

Trevogrumab




Synonyms REGN1033











Identifiers
CAS Number 1429201-24-0



ChemSpider none
UNII 87T4327873
KEGG D11242


Chemical data


Chemical formula C6374H9884N1696O2018S46
Molecular weight 144.0 g/mol





Trevogrumab (INN[1]) (REGN1033) is a human monoclonal antibody designed for the treatment of muscle atrophy due to orthopedic disuse and sarcopenia.

This drug was developed by Regeneron Pharmaceuticals, Inc.[2]

References[edit]

  1. World Health Organization."International Nonproprietary Names for Pharmaceutical Substances (INN). Proposed INN: List 113".WHO Drug Information.2015;29(2)Full text.
  2. Statement On A Nonproprietary Name Adopted By The USAN Council - Trevogrumab, American Medical Association.


Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.